The NIH analytical methods and reference materials program for dietary supplements

Analytical and Bioanalytical Chemistry

Volumn 389, Issue 1, 2007, Pages 19-25

  Betz, Joseph M ^a   Fisher, Kenneth D ^a   Saldanha, Leila G ^a   Coates, Paul M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bioanalytical methods; Natural products; Quality assurance control; Reference materials

Indexed keywords

HEALTH CARE; PESTICIDES; QUALITY ASSURANCE; QUALITY CONTROL;

BIOANALYTICAL METHODS; DIETARY SUPPLEMENTS (DS); OFFICE OF DIETARY SUPPLEMENTS (ODS); REFERENCE MATERIALS;

FOOD PRODUCTS;

DIET SUPPLEMENTATION; HEALTH CARE ORGANIZATION; REVIEW; STANDARD; UNITED STATES;

DIETARY SUPPLEMENTS; NATIONAL INSTITUTES OF HEALTH (U.S.); REFERENCE STANDARDS; UNITED STATES;

EID: 34548211822     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-007-1342-8     Document Type: Review

References (47)

1. FDA (1994) Dietary Supplement Health and Education Act of 1994 (United States Public Law 103-417; 103rd Cong., 25 October 1994). Food and Drug Administration, Department of Health and Human Services, Washington, DC
2. Hoffman FA (2001) Clin Obstet Gynecol 44:780-788
3. Commission on Dietary Supplement Labels (1997) Report of the Commission on Dietary Supplement Labels. US Government Printing Office, Washington, DC, p 17
4. Sarubin A (2000) The health professional's guide to popular dietary supplements. The American Diatetic Association, Chicago, IL, p 3
5. Israelsen LD, Barrett M (2004) History and regulation of botanicals in the United States. In: Barrett M (ed) The handbook of clinically tested herbal remedies. Haworth, Binghamton, NY, pp 3-12
6. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D (1996) BMJ 313:253-258
7. Fenyvesi C (1998) US News and World Report, January 19, p 70
8. Greenwald J (1998) Time, November 23, p 152
9. Blumenthal M (2003) The ABC clinical guide to herbs. Thieme, New York, NY, p xviii
10. Monmaney T (1998) Los Angeles Times, August 31, p A1
11. Foreman J (2000) Boston Globe, January 10, Health/Science p 1
12. Draves AH, Walker SE (2003) Can J Clin Pharmacol 10:114-118
13. Edwards DJ, Draper EJ (2003) J Am Pharm Assoc 43:419-423
14. Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM (2001) J Clin Nutr 73:1101-1106
15. Petty HR, Fernando M, Kindzelskii AL, Zarewych BN, Ksebati MB, Hryhorczuk LM, Mobashery S (2001) Chem Res Toxicol 14:1254-1258
16. Li W, Sun Y, Fitzloff JF, van Breeman RB (2002) Chem Res Toxicol 15:1174-1178
17. Li W, Fitzloff JF, Farnsworth NR, Fong HH (2002) Phytomedicine 9:442-446
18. Ernst E (2004) Pharmacoepidemiol Drug Saf 13:767-771
19. Food and Drug Administration (2003) Proposed rule for the establishment of good manufacturing practices for dietary supplements. Federal Register 68:12157-12263
20. FDA (2006) Current good manufacturing practice in manufacturing, packing, or holding human food (Title 21 Code of Federal Regulations Part 110). Food and Drug Administration, Department of Health and Human Services, Washington, DC
21. Swanson CA (2002) Am J Clin Nutr 75:8-10
22. National Center for Complementary and Alternative Medicines (2007) Biologically active agents used in CAM and placebo materials-policy and guidance. http://nccam.nih.gov/research/policies/bioactive.htm. Cited 21st March 2007
23. Busse W (2000) Drug Information J 34:15-23
24. European Directorate for the Quality of Medicines (2003) Herbal drugs (1433). In: European Pharmacopoeia, 4th edn. European Directorate for the Quality of Medicines, Strasbourg, p 510
25. European Directorate for the Quality of Medicines (2003) Herbal drug preparations (1434). In: European Pharmacopoeia, 4th edn. European Directorate for the Quality of Medicines, Strasbourg, p 510
26. American Herbal Products Association (2003) Standardization of botanical products: White Paper. American Herbal Products Association, Silver Spring, MD, p 33
27. Butterweck V (2003) CNS Drugs 17:539-562
28. Mueller SC, Majcher-Peszynska J, Uehleke B, Klammt S, Mundkowski RG, Miekisch W, Sievers H, Bauer S, Frank B, Kundt G, Drewelow B (2006) Eur J Clin Pharmacol 62:29-36
29. Gutmann H, Poller B, Buter KB, Pfrunder A, Schaffner W, Drewe J (2006) Planta Med 72:685-690
30. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ (1996) Control Clin Trials 17:1-12
31. Moher D, Schulz KF, Altman DG (2001) Ann Intern Med 134:657-662
32. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C (2005) Ann Intern Med 144:364-367
33. Wolsko PM, Solondz DK, Phillips RS, Schachter SC, Eisenberg DM (2005) Am J Med 118:1087-1093
34. Gagnier JJ, DeMelo J, Boon H, Rochon P, Bombardier C (2006) Am J Med 119:800e1-800e11
35. Harkin T (2003) Committee Report 5 of 100: Senate Rpt. 107-084: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Bill. US Government Printing Office, Washington, DC, pp 183-184
36. Saldahna LG, Betz JM, Coates PM (2004) J AOAC Int 87:162-165
37. Roman MC (2004) J AOAC Int 87:1-14
38. Trujillo WA, Sorenson WR (2003) J AOAC Int 86:643-656
39. Zhou JZ, Waszkuc T, Mohammed F (2005) J AOAC Int 88:1048-1058
40. Szpylka J, DeVries JW (2005) J AOAC Int 88:1279-1291
41. Gray D, LeVanseler K, Pan M, Waysek EH (2007) J AOAC Int 90:43-54
42. Sorenson WR, Sullivan D (2006) J AOAC Int 89:22-34
43. Trujillo WA, Sorenson WR, La Luzerne P, Austad JW, Sullivan D (2006) J AOAC Int 89:942-959
44. Sharpless KE, Anderson DL, Betz JM, Butler TA, Capar SG, Cheng J, Fraser CA, Gardner G, Gay ML, Howell DW, Ihara T, Khan MA, Lam JW, Long SE, McCooeye M, Mackey EA, Mindak WR, Mitvalsky S, Murphy KE, NguyenPho A, Phinney KW, Porter BJ, Roman M, Sander LC, Satterfield MB, Scriver C, Sturgeon R, Thomas JB, Vocke RD Jr, Wise SA, Wood LJ, Yang L, Yen JH, Ziobro GC (2006) J AOAC Int 89:1483-1495
45. Sander LC, Sharpless KE, Wise SA (2006) Life Sci 78:2044-2048
46. Roman MC, Betz JM, Hildreth J (2007) J AOAC Int 90:68-81
47. Trucksess MW, Weaver C, Oles C, D'Ovidio K, Rader J (2006) J AOAC Int 89:624-630